NDC 0641-6050-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6050
- Requested NDC
- 0641-6050-01
- Package NDCs from labels
- 0641-6050-01, 0641-6050-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-10 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6050-01 | Lorazepam | 10 mL in 1 VIAL | INJECTION | 10 | 9 | |
| 0641-6050-10 | Lorazepam | 10 in 1 CARTON | INJECTION | 10 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6050-01 | ML - Milliliter | 0641-6050 | 3876a2fe-74f1-42c2-934e-f5e4b4b83bae | 1 | 2012-07-24 |
| 0641-6050-10 | ML - Milliliter | 0641-6050 | 268d159a-ce50-4de9-a0df-8d59cbdb0754 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Revitalize Energizing Eye Drops | NAPHAZOLINE HYDROCHLORIDE ,PROPYLENE GLYCOL | Revitalize Energy Inc. | 518aac87-1642-4b2f-bca1-b74d21261eea | 2026-07-16 | Warnings | 6DC9Q167V3 |
| Lorazepam | LORAZEPAM | ANI Pharmaceuticals, Inc. | 787240e9-67b5-4af3-b16d-7cf314e3f2e3 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Hospira, Inc. | 20140b19-846b-425f-b191-670e17809945 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | d6364be4-056b-4ebe-83bc-3fc85e8f488c | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | St. Mary's Medical Park Pharmacy | 56093df3-10f6-e747-e063-6294a90a6564 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | St. Mary's Medical Park Pharmacy | 569e8a5a-ddf7-ebbc-e063-6294a90ab7a4 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | b707ecb2-644c-4323-ab0e-7bc5929cd560 | 2026-06-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Unit Dose Solutions, Inc. | 5519bba8-9eb7-a3e0-e063-6294a90afd94 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Unit Dose Solutions, Inc. | 551a1b7f-d342-2c53-e063-6394a90a9a2a | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | LKG8494WBH |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 0cd02e52-ead5-4b2a-9708-c7c4be7b7995 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Coupler LLC | 54d72943-f8d1-5a78-e063-6294a90a059b | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Redpharm Drug | 5407f327-3a22-8c15-e063-6294a90a3169 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Visine Red Eye Total Comfort Multi-Symptom | TETRAHYDROZOLINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 400, AND ZINC SULFATE, UNSPECIFIED FORM | Kenvue Brands LLC | 5747edef-7a87-41d7-9594-6c78508b9ba2 | 2026-06-11 | Warnings | B697894SGQ |
| LORAZEPAM | LORAZEPAM | REMEDYREPACK INC. | 7fa1a011-5e28-4b13-bcd2-5c5fc9b663b2 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | Bryant Ranch Prepack | 46af8e93-3169-408a-b4d8-b8498642801d | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| VitaPhyte Redness Reliever Lubricant Eye Drops | REDNESS RELIEVER LUBRICANT EYE DROPS | Guangzhou Liyan Cosmetics Technology Co., Ltd. | 53d4e9b0-c9a0-797a-e063-6294a90ad0cf | 2026-06-04 | Warnings | B697894SGQ |
| Visine Red Eye Hydrating Comfort Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Savings Distributors LLC | 558178eb-1eec-af0f-e063-6394a90afad9 | 2026-06-01 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals Inc. | 4a50329b-b272-4164-bddf-0d6cea3d7a23 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Blink Triple Care Preservative Free | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | 65e67990-78b7-4ce9-963b-6bed3a6bed07 | 2026-05-27 | Warnings | B697894SGQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.